Loading…
Lobbying Spend
—
Filings
41
Firms Hired
1
Active Period
2004–2016
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: —
Matched citations: HR 1320
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: —
Matched citations: S 608
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: —
Matched citations: HR 1320
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: —
Matched citations: S 608
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: —
Matched citations: HR 1320
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: —
Matched citations: S 608
Lobbying related to Medicare reimbursement for GI procedures and services, as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cnacer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: —
Matched citations: HR 1320
Lobbying related to Medicare reimbursement for GI procedures and services, as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cnacer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: —
Matched citations: S 608
Lobbying related to Medicare reimbursement for GI Procedures and services as well as ambulatory surgey centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cancer prevention, Medicare reimbursement rates, and medicare screening rates.
Client expense: — · Firm income: —
Matched citations: HR 1320
Lobbying related to Medicare reimbursement for GI Procedures and services as well as ambulatory surgey centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cancer prevention, Medicare reimbursement rates, and medicare screening rates.
Client expense: — · Firm income: —
Matched citations: S 608
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is realted to colorectal cancer prevention, Medicare reimbursement rates and Medicare screening rates.
Client expense: — · Firm income: —
Matched citations: HR 1320
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is realted to colorectal cancer prevention, Medicare reimbursement rates and Medicare screening rates.
Client expense: — · Firm income: —
Matched citations: S 608
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs), and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: $14,500
Matched citations: HR 1320
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs), and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: $14,500
Matched citations: S 608
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs), and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: $22,500
Matched citations: HR 1320
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs), and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 1320 and S 608, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: $22,500
Matched citations: S 608
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs), and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 3198, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: $22,500
Matched citations: HR 3198
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs), and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 3198, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: $22,500
Matched citations: HR 3198
Lobbying related to Medicare reimbursement for GI procedures and services as well as ambulatory surgery centers (ASCs), and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 3198, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: $22,500
Matched citations: HR 3198
Lobbying related to Medicare reimbursement for GI procedures and services, as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 3198, which is related to colorectal cancer prevention, Meddicar reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: $22,500
Matched citations: HR 3198
Lobbying related to Medicare reimbursement for GI procedures and services, as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 3198, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: $22,500
Matched citations: HR 3198
Lobbying related to Medicare reimbursement for GI procedures and services, as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to the Screen Act, HR 3198, which is related to colorectal cancer prevention, Medicare reimbursement rates, and Medicare screening rates.
Client expense: — · Firm income: $22,500
Matched citations: HR 3198
Supporting ColoRectal Examination and Education Now (SCREEN) Act of 2009
2010 · fourth_quarter · Firm: MS. JOANN WILLIS
Lobbying related to Medicare reimbursement for GI procedures and services, as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to HR 3559 and S 1511, the Screen Act, related to colorectal cancer prevention and Medicare screening rates.
Client expense: — · Firm income: $22,500
Matched citations: HR 3559
Supporting ColoRectal Examination and Education Now (SCREEN) Act of 2009
2010 · fourth_quarter · Firm: MS. JOANN WILLIS
Lobbying related to Medicare reimbursement for GI procedures and services, as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to HR 3559 and S 1511, the Screen Act, related to colorectal cancer prevention and Medicare screening rates.
Client expense: — · Firm income: $22,500
Matched citations: S 1511
Supporting ColoRectal Examination and Education Now (SCREEN) Act of 2009
2010 · third_quarter · Firm: MS. JOANN WILLIS
Lobbying related to Medicare reimbursement for GI procedures and services, as well as ambulatory surgery centers (ASCs) and infection control in the ambulatory setting. Lobbying related to HR 3559 and S 1511, the Screen Act, related to colorectal cancer prevention and Medicare screening rates.
Client expense: — · Firm income: $22,500
Matched citations: HR 3559
Source: Senate LDA